The Australian government has announced that it will accept Chinese-made Sinovac and Indian-made AstraZeneca (Covishield) vaccines.
The Australian government announced after Australia decided to reopen borders that had been closed due to the Covid-19 epidemic and to ease restrictions.
Australia’s vaccination process has also made significant progress, reaching 80 percent of its target, according to media reports. Australia is one of the countries that has imposed strict border restrictions due to the Covid-19 epidemic.
With Australia announcing that the Chinese-made Sinovac biotech vaccine and the Indian-made AstraZeneca vaccine are recognized in the country, foreign tourists and paid foreign students studying in Australia will have the opportunity to enter Australia.
The Australian Drug Regulatory Authority, the Therapeutic / Medical Product Administration, has announced that Sinovac and India-made AstraZeneca (Covishield) vaccines are ‘accepted vaccines’. Australia’s Prime Minister Scott Morrison has explained that this will allow vaccinated foreigners to enter Australia.
The Chinese-made Sinovac vaccine has been approved by the World Health Organization for emergency use but has not been approved by the United Kingdom, New Zealand, and many other Western European countries.
The Sinovac vaccine, also known as CoronaVac, is now widely accepted in several European countries as part of its immunization program.
Foreign media reports that the United States will make a similar decision. The United States is preparing to open the country to foreigners, and the implementation of those plans will allow vaccinated foreigners to enter the country.
The Covid-19 epidemic has closed thousands of foreign students in Australia. International education services are a major source of revenue for Australia, and in 2019, the state of New South Wales in Australia alone, including Sydney, received $ 14.6 billion (the US $ 11 billion) in revenue from international education services.